Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717691 · ClinicalTrials.gov registry record · NA
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
A NA study of Hallux Limitus, sponsored by Dynasplint Systems.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT00717691 is a NA study of Hallux Limitus that has completed, run by Dynasplint Systems. The registered enrollment target is 50 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT00717691, a NA study of Hallux Limitus, has completed, sponsored by Dynasplint Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Metatarsophalangeal Extension Dynasplint System
Study Locations (2)
Georgia
- Atlanta Foot and Leg Clinic - Jonesboro
- Ankle and Foot Centers, PC - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717691
The ClinicalTrials.gov registry entry for NCT00717691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dynasplint Systems, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hallux Limitus appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT00717691 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00717691 about?
NCT00717691 is a clinical study titled "Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial". The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.
What is the current status of trial NCT00717691?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2008-12.
What conditions does trial NCT00717691 study?
This clinical trial studies the following conditions: Hallux Limitus.
What interventions are being tested in trial NCT00717691?
The interventions under investigation include: Standard of Care (OTHER), Metatarsophalangeal Extension Dynasplint System (DEVICE).
Who is sponsoring clinical trial NCT00717691?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00717691 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.